Cargando…

Pediatric growth patterns in youth‐onset type 2 diabetes mellitus: Implications for physiologically‐based pharmacokinetic models

An accurate understanding of the changes in height and weight of children with age is critical to the development of models predicting drug concentrations in children (i.e., physiologically‐based pharmacokinetic models). However, curves describing the growth of a typical population of children may n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosey, Chelsea M., Halpin, Kelsee, Shakhnovich, Valentina, Bi, Chengpeng, Sweeney, Brooke, Yan, Yun, Leeder, J. Steven
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9010268/ https://www.ncbi.nlm.nih.gov/pubmed/35297172 http://dx.doi.org/10.1111/cts.13207

Ejemplares similares

LBODP083 Pharmacokinetics Of Metformin In Obese Non-diabetic Youth: Drug Clearance Increases With Severity Of Obesity
por: Halpin, Kelsee, et al.
Publicado: (2022)

ODP383 Clinical Presentation and Management of Diabetes Mellitus in Youth with Prader-Willi Syndrome
por: Paprocki, Emily, et al.
Publicado: (2022)

Efficacy of Weight Reduction on Pediatric Nonalcoholic Fatty Liver Disease: Opportunities to Improve Treatment Outcomes Through Pharmacotherapy
por: Friesen, Chance S., et al.
Publicado: (2021)

Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective
por: Friesen, Chance S., et al.
Publicado: (2021)

Trends in HbA1c Change Among Youth Referred to a Pediatric Type 2 Diabetes Prevention Clinic
por: Paprocki, Emily, et al.
Publicado: (2021)

PMON188 Frequency of Hemoglobin A1c and Body Mass Index Increase in Youth at Risk for Developing Type 2 Diabetes Mellitus During the COVID-19 Pandemic
por: Wee, Erica, et al.
Publicado: (2022)

Ontogeny-related pharmacogene changes in the pediatric liver transcriptome
por: Meier, Richard, et al.
Publicado: (2018)

SAT-144 Can Point-of-Care Betahydroxybutyrate Testing Be Used to Predict Diabetic Ketoacidosis in the Pediatric Emergency Department?
por: Knoll, Michelle, et al.
Publicado: (2019)

Are body surface area based estimates of liver volume applicable to children with overweight or obesity? An in vivo validation study
por: Hosey‐Cojocari, Chelsea, et al.
Publicado: (2021)

Progression of comorbidities in youth with overweight or obesity during the COVID-19 pandemic
por: Wee, Erica, et al.
Publicado: (2023)

Hyperglycemia Requiring Insulin Among Pediatric Patients Diagnosed With Hemophagocytic Lymphohistiocytosis
por: Schweisberger, Cintya, et al.
Publicado: (2021)

FRI473 Central Hypothyroidism Following Neonatal Graves Presentation
por: Metzinger, Emily, et al.
Publicado: (2023)

Alternative Splicing of the SLCO1B1 Gene: An Exploratory Analysis of Isoform Diversity in Pediatric Liver
por: van Groen, Bianca D., et al.
Publicado: (2020)

LBODP029 Pseudohypobicarbonatemia In The Setting Of Diabetic Ketoacidosis And Severe Hypertriglyceridemia
por: Lamb, Seth, et al.
Publicado: (2022)

SAT-LB93 Rapid Reduction of Insulin Requirement in a Hyperglycemic Patient Treated for Hemophagocytic Lymphohistiocytosis
por: Schweisberger, Cintya, et al.
Publicado: (2020)

Vague neuroglycopenic complaints camouflage diagnosis of adolescent insulinoma: a case report
por: Halpin, Kelsee, et al.
Publicado: (2016)

Ontogeny Related Changes in the Pediatric Liver Metabolome
por: Wilson, Christopher M., et al.
Publicado: (2020)

Pharmacokinetics of Asfotase Alfa in Adult Patients With Pediatric‐Onset Hypophosphatasia
por: Pan, Wei‐Jian, et al.
Publicado: (2021)

Clinical & immunological profile of newly diagnosed patients with youth onset diabetes mellitus
por: Dhanwal, D.K., et al.
Publicado: (2014)

Physiologically Based Pharmacokinetic Modeling and Simulation in Pediatric Drug Development
por: Maharaj, A R, et al.
Publicado: (2014)

Physiologically-Based Pharmacokinetic (PBPK) Modeling Providing Insights into Fentanyl Pharmacokinetics in Adults and Pediatric Patients
por: Kovar, Lukas, et al.
Publicado: (2020)

Physiologically‐Based Pharmacokinetic Modeling vs. Allometric Scaling for the Prediction of Infliximab Pharmacokinetics in Pediatric Patients
por: Malik, Paul R. V., et al.
Publicado: (2019)

Habitat loss for black flying foxes and implications for Hendra virus
por: Baranowski, Kelsee, et al.
Publicado: (2023)

Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug–Gene Pairs to Know
por: Sandritter, Tracy, et al.
Publicado: (2023)

Sleep Challenges in Children with Prader-Willi Syndrome: A Patient and Family Handout
por: Ingram, David G., et al.
Publicado: (2021)

Sleep Disorders in Children with Prader Willi Syndrome: Current Perspectives
por: Ingram, David G, et al.
Publicado: (2022)

A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations
por: Talha Zahid, Muhammad, et al.
Publicado: (2023)

Physiologically Based Pharmacokinetic Models Are Effective Support for Pediatric Drug Development
por: Wang, Kefei, et al.
Publicado: (2021)

Estimation of Pediatric Dosage of Antimalarial Drugs, Using Pharmacokinetic and Physiological Approach
por: Mhango, Ellen K. G., et al.
Publicado: (2023)

Decreased Pregnane X Receptor Expression in Children with Active Crohn’s Disease
por: Shakhnovich, Valentina, et al.
Publicado: (2016)

Population Pharmacokinetic Analysis of Dalteparin in Pediatric Patients With Venous Thromboembolism
por: Damle, Bharat, et al.
Publicado: (2020)

Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care
por: Hartz, Jacob C, et al.
Publicado: (2018)

The Coronavirus Disease 2019 Pandemic is Associated with a Substantial Rise in Frequency and Severity of Presentation of Youth-Onset Type 2 Diabetes
por: Magge, Sheela N., et al.
Publicado: (2022)

A Retrospective Evaluation of Allometry, Population Pharmacokinetics, and Physiologically‐Based Pharmacokinetics for Pediatric Dosing Using Clearance as a Surrogate
por: Wu, Qier, et al.
Publicado: (2019)

Population Pharmacokinetic Model for Ertugliflozin in Healthy Subjects and Patients With Type 2 Diabetes Mellitus
por: Fediuk, Daryl J., et al.
Publicado: (2020)

Pharmacokinetics and Pharmacological Activities of Berberine in Diabetes Mellitus Treatment
por: Han, Yunfeng, et al.
Publicado: (2021)

Physiologically Based Pharmacokinetic Modeling of Monoclonal Antibodies in Pediatric Populations Using PK-Sim
por: Basu, Sumit, et al.
Publicado: (2020)

Increasing application of pediatric physiologically based pharmacokinetic models across academic and industry organizations
por: Johnson, Trevor N., et al.
Publicado: (2022)

Physiologically based pharmacokinetic modeling of daptomycin dose optimization in pediatric patients with renal impairment
por: Ye, Lingling, et al.
Publicado: (2022)

ODP420 Ovarian Venous Sampling and the Diagnostic Challenges Associated with Identifying the Source of Severe Hyperandrogenism in an Adolescent Female
por: Halpin, Kelsee, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_13q68e13d5qo7rq1uigmpvet8o